-
OICR-DAC, Ontario Institute for Cancer Research; Biliary Tract Cancer
Dac
EGAC50000000528
-
Elucidating the molecular landscape of KRAS/BRAF mutant colorectal cancers
Study
EGAS00001007459
-
Brain Cancer Center Committee
Dac
EGAC00001003523
-
Proteogenomic Characterization Unveils Biomarkers Associated With Chemoresistance in Muscle Invasive Bladder Cancer
Study
phs004049
-
CSER: Evaluating Utility and Improving Implementation of Genomic Sequencing for Pediatric Cancer Patients in the Diverse Population and Healthcare Settings of Texas: The KidsCanSeq Study
Study
phs002378
-
Childhood Cancer Data Initiative (CCDI): NCI-COG Pediatric MATCH Precision Medicine Clinical Trial
Study
phs002883
-
Epigenomics of Neurocognitive Function in Breast Cancer
Study
phs003959
-
Identifying and Reducing Disparities in Patient-Reported Outcomes Among African American Prostate Cancer Survivors
Study
phs003745
-
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to the Antibody Drug Conjugate Sacituzumab Govitecan
Study
phs002555
-
A Phase II Study: CRS207/GVAX Plus Anti-PD1 and Anti-CTLA4 Recruits Mesothelin- and KRAS-Specific T cells into PDAC
Study
phs003798